CAPITOL 6 ADVISORS

Lobbying for AMGEN · Biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

FY 2026 Labor, Health and Human Services, and Education appropriations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem